Fundraising FoxGeneral Oncology
Brookline, US · Founded 2015 · Delaware corporation
Find your way into General Oncology
Sign up to see every warm intro you have to General Oncology
- Paths you didn't know you had: your email and LinkedIn already hold routes to the General Oncology team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Founders & leadership
AA
Abid AnsariExecutive
JA
Jeffrey Aaron GlazierExecutive
AG
Arnold GlazierNamed on SEC filing
HE
Henry EsberNamed on SEC filing
GG
Gregg GoldsteinNamed on SEC filing
Board
MP
Michael PetitBoard director
BS
Barry SeemanBoard director
Reported raises · per SEC filings
Form D private placements$50.5M disclosed across 3 rounds · 2015–2026
▶$4.8MraisedApr 2026 · 37 investors · PharmaceuticalsRule 506(b)
▶$4.8MraisedApr 2026 · 37 investors · Pharmaceuticals
Rule 506(b)Officers, directors & promoters on the filing
- Barry SeemanDirector
- Arnold GlazierExecutive Officer, Director
- Michael J. PetitDirector
- Jeffrey Aaron GlazierExecutive Officer, Director
- Abid AnsariExecutive Officer
- Offering amount
- $4.8M
- Amount sold
- $4.8M
- First sale
- Apr 2026
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$10.9MraisedJul 2025 · 43 investors · PharmaceuticalsRule 506(b)
▶$10.9MraisedJul 2025 · 43 investors · Pharmaceuticals
Rule 506(b)Officers, directors & promoters on the filing
- Michael PetitDirector
- Arnold GlazierExecutive Officer, Director
- Michael PetitDirector
- Abid AnsariExecutive Officer
- Barry SeemanDirector
- Jeffrey Aaron GlazierExecutive Officer, Director
- Offering amount
- $17.3M
- Amount sold
- $10.9M
- First sale
- Jun 2019
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$34.8MraisedSep 2017 · 140 investors · BiotechnologyRule 506(b)
▶$34.8MraisedSep 2017 · 140 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Arnold GlazierExecutive Officer, Director
- Henry EsberDirector
- Gregg GoldsteinExecutive Officer, Director
- Offering amount
- $46.9M
- Amount sold
- $34.8M
- First sale
- Nov 2015
- Incorporated
- Corporation, Delaware, 2015
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- How much funding has General Oncology raised?
- General Oncology has disclosed $50.5M raised across 3 rounds.
- Where is General Oncology headquartered?
- General Oncology is headquartered in Brookline, US.